Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies.

Qian Z, Qian J, Lin J, Yao DM, Chen Q, Ji RB, Li Y, Xiao GF, Li JY.

J Exp Clin Cancer Res. 2010 Aug 12;29:111. doi: 10.1186/1756-9966-29-111.

2.

Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia.

Qian J, Qian Z, Lin J, Yao DM, Chen Q, Li Y, Ji RB, Yang J, Xiao GF, Wang YL.

Leuk Res. 2011 Jun;35(6):783-6. doi: 10.1016/j.leukres.2010.10.013. Epub 2010 Nov 11.

PMID:
21074269
3.

[Quantification of GRAF gene expression in patients with acute myeloid leukemia using EvaGreen real time quantitative PCR].

Qian Z, Lin J, Qian J, Yao DM, Wang YL, Han LX, Zhu ZH, Xiao GF.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Jun;27(3):290-3. doi: 10.3760/cma.j.issn.1003-9406.2010.0.012. Chinese.

PMID:
20533268
4.

Methylation status of DDIT3 gene in chronic myeloid leukemia.

Wang YL, Qian J, Lin J, Yao DM, Qian Z, Zhu ZH, Li JY.

J Exp Clin Cancer Res. 2010 May 23;29:54. doi: 10.1186/1756-9966-29-54.

5.

High expression of GTPase regulator associated with the focal adhesion kinase (GRAF) is a favorable prognostic factor in acute myeloid leukemia.

Aly RM, Ghazy HF.

Blood Cells Mol Dis. 2014 Dec;53(4):185-8. doi: 10.1016/j.bcmd.2014.07.004. Epub 2014 Jul 23.

PMID:
25088035
6.

[Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].

Zhu Y, Xu W, Liu Q, Pan J, Qiu H, Wang R, Qiao C, Jiang Y, Zhang S, Fan L, Zhang J, Shen Y, Xue Y, Li J.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Oct;25(5):579-82. Chinese.

PMID:
18841577
7.

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.

Boultwood J, Pellagatti A, Watkins F, Campbell LJ, Esoof N, Cross NC, Eagleton H, Littlewood TJ, Fidler C, Wainscoat JS.

Br J Haematol. 2004 Aug;126(4):508-11.

PMID:
15287943
9.

[Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].

Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND.

Ter Arkh. 2007;79(4):49-53. Russian.

PMID:
17564019
10.

Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

Bacher U, Haferlach C, Alpermann T, Kern W, Schnittger S, Haferlach T.

Haematologica. 2011 Sep;96(9):1284-92. doi: 10.3324/haematol.2011.043687. Epub 2011 May 23.

11.

Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.

Gaiger A, Henn T, Hörth E, Geissler K, Mitterbauer G, Maier-Dobersberger T, Greinix H, Mannhalter C, Haas OA, Lechner K, Lion T.

Blood. 1995 Sep 15;86(6):2371-8.

12.

High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.

Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL, Dastugue N, Macintyre E, Denis C, Bauters F, Kerckaert JP, Cosson A, Fenaux P.

Blood. 2000 Oct 15;96(8):2862-9.

13.

[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].

Qin YZ, Ruan GR, Liu YR, Li JL, Fu JY, Wang H, Chang Y, Jiang B, Jiang Q, Jiang H, Qiu JY, Chen SS, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):1-5. Chinese.

PMID:
15946498
14.

Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.

Mann KP, DeCastro CM, Liu J, Moore JO, Bigner SH, Traweek ST.

Am J Clin Pathol. 1997 Jun;107(6):653-60.

PMID:
9169661
16.

The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

Borkhardt A, Bojesen S, Haas OA, Fuchs U, Bartelheimer D, Loncarevic IF, Bohle RM, Harbott J, Repp R, Jaeger U, Viehmann S, Henn T, Korth P, Scharr D, Lampert F.

Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9168-73.

17.

Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia.

Bueso-Ramos CE, Rocha FC, Shishodia S, Medeiros LJ, Kantarjian HM, Vadhan-Raj S, Estrov Z, Smith TL, Nguyen MH, Aggarwal BB.

Hum Pathol. 2004 Feb;35(2):246-53.

PMID:
14991544
18.

ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.

Haferlach C, Bacher U, Schnittger S, Alpermann T, Zenger M, Kern W, Haferlach T.

Genes Chromosomes Cancer. 2012 Apr;51(4):328-37. doi: 10.1002/gcc.21918. Epub 2011 Dec 8.

PMID:
22162288
19.

Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.

Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.

Cancer Res. 2000 Feb 1;60(3):610-7.

20.

Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.

Reins J, Mossner M, Neumann M, Platzbecker U, Schumann C, Thiel E, Hofmann WK.

Leuk Res. 2010 Dec;34(12):1610-6. doi: 10.1016/j.leukres.2010.04.013. Epub 2010 May 14.

PMID:
20471677

Supplemental Content

Support Center